"Bisphossy jaw": an adverse drug reaction with bisphosphonates

Deborah Layton*, Anthony Cox

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Bisphosphonates are used to treat osteoporosis, other bone diseases, multiple myeloma and skeletal events associated with metastatic neoplasm.

There have been concerns of an association between oral bisphosphonate use and osteonecrosis of the jaws (ONJ), which we have termed “bisphossy jaw”.
Original languageEnglish
Pages (from-to)331-332+338
JournalPharmaceutical Journal
Issue number7571
Publication statusPublished - 1 Sept 2009


Dive into the research topics of '"Bisphossy jaw": an adverse drug reaction with bisphosphonates'. Together they form a unique fingerprint.

Cite this